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gioplasty procedure (RR ¼ 0.4, 95% CI ¼ 0.46-1.5, p¼0.48). Thirteen
veins developed in-stent restenosis. Five of these veins were treated
with a stent-in-stent, this was successful in four of these veins (80%).
In the eight vessels where angioplasty was used for in-stent stenosis,
4 vessels developed recurrence (50%). Complications were similar; 1
patient treated with a stent had impingement of the adjacent vein
requiring a second stent. In the angioplasty group 1 patient developed
transient ST elevations and hypotension and 1 patient experienced PV
perforation requiring intubation.
CONCLUSIONS The use of large stents can signiﬁcantly reduce the
risk of restenosis and are more effective than simple balloon angio-
plasty. However restenosis remains common and warrants on going
surveillance after the initial procedures. This may suggest a role for
novel approaches including the use of drug coated balloons.
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BACKGROUND Secundum atrial septal defects (ASD) are treated by
surgery (SC) or transcatheter closure (TCC). There is no clear superi-
ority of one technique and there is a scarcity of data directly
comparing TCC and SC. This meta-analysis compares the clinical
outcomes of the two treatment options for ASD.
METHODS A literature search was performed in MEDLINE, Embase,
PubMed, Google Search, and Cochrane databases. Only studies
directly comparing SC and TCC of ASDs were included. Of note, by
deﬁnition and as a limitation of this work, this study compares only
device-closeable ASD’s (TCC) to all surgically closed ASD’s. Outcomes
studied were major and minor acute complications, all-cause mor-
tality, residual shunt, reinterventions, ICU admission, and length of
stay (LOS). Odds ratios (OR), standardized mean difference (SMD) and
95% conﬁdence intervals (CI) were calculated using the Mantel-
Haenszel method. A random-effect model was used to obtain sum-
mary effect. Sensitivity and cumulative analysis was performed for
each outcome. All ages were included.
RESULTS 1287 manuscripts were screened. Twenty studies fulﬁlled
the inclusion criteria: all observational studies (total n ¼ 4,673 pa-
tients). TCC was superior to SC for the following outcomes: total
complications (OR 0.33, 95% CI 0.20 to 0.75; p <0.01), major compli-
cations (OR 0.42, 95% CI 0.25 to 0.71; p <0.01), minor complications
(OR 0.31, 95% CI 0.16 to 0.57; p <0.01), ICU admission (OR 0.01, 95% CI
0.01 to 0.29; p ¼0.01), and LOS (SMD -2.33, 95% CI -2.81 to -1.85;
p <0.01). Residual shunts were more common with TCC (OR 3.28, 95%
CI 1.57 to 6.87; p <0.01). No difference was observed for all-cause
mortality (OR 0.34, 95% CI 0.08 to 1.49; p ¼0.15) or the need of
reintervention (OR 1.39, 95% CI 0.49 to 3.96; p ¼0.61). Amongst adult
patients (>18 years) a TCC was associated with shorter LOS (SMD -2.13,
95% CI -2.39 to -1.88; p <0.01).
CONCLUSIONS We present the largest meta-analysis comparing TCC
and SC for closure of secundum ASD. Though both approaches are
efﬁcacious, for TCC-appropriate ASD’s, TCC is associated with
shorter LOS, less morbidity and fewer ICU admissions, while SC has a
lower rate of residual shunting. Of note, many surgical cases
included in this meta-analysis likely could only be closed surgically
suggesting that both approaches are of value in the care of patients
with ASD.CATEGORIES STRUCTURAL: Congenital and Other Structural Heart
Disease
KEYWORDS Atrial septal defect, Closure device, Surgery
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BACKGROUND Percutaneous closure of atrial septal defect (ASD) with
a self-expandable double-disk ASD septal closure device is a well-
accepted technique. Recently, concerns were raised about some rare
but catastrophic long-term complications such as aortic erosion.
Factors that contribute to this adverse outcome have not been
recognized. Intracardiac echocardiography (ICE) can be used to guide
device implantation, immediate results and to evaluate device
deformation. We hypothesized that additional deformation of the
disks of the implanted device may occur independently of its waist
compression. The importance of such deformations and their impact
on surrounding tissues is not known.
METHODS Consecutive patients undergoing percutaneous ASD
closure guided by ICE were enrolled. Defect sizing was conducted
with color-Doppler at “stop-ﬂow” during balloon deployment. ICE
loops were recorded and retrospectively studied. The length of the
compartments of the closure device was measured at horizontal
plane. Subsequently, in order to evaluate device deformation, the
ratio of the measured to the nominal dimensions of the device was
produced. Namely, R-waist (R-W), R-left-atrial-disk (R-LA) and R-
right-atrial-disk (R-RA) were calculated.
RESULTS A total of 25 patients were included in the study. In all cases
ASD was conducted uneventfully. R-W was 0.65  0.13, R-LA was 0.85
 0.09 and R-RA was 0.84  0.07. R-W differed signiﬁcantly compared
to the observed deformation of both disks (R-LA and R-RA), p<0.001.
However, R-W was neither correlated with R-LA (r¼0.175, p¼0.404)
nor with R-RA (r¼0.123, p¼0.558). This indicates that other factors
besides mechanical properties of the device affect disks expansion.
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tively correlated (r¼0.413, p¼0.04).
CONCLUSIONS While a minimal deformation of the waist of the ASD
device is expected due to a relative intentional oversizing, in the
present study the observed deformation of the disks of the device was
not correlated with the deformation of the waist. Therefore potential
mechanisms for this deformation, such as mechanical tension from
adjacent structures, should be investigated in future studies.
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BACKGROUND Drug therapy (DT) for ventricular tachycardia (VT) is
not very effective and is fraught with pro-arrhythmic and other
adverse effects. Catheter ablation (CA) of VT is considered an effective
alternative to DT.
METHODS PubMed, EBSCO and Ovid databases were searched to
identify studies comparing CA and DT for the management of VT in
structural heart disease. Studies reporting outcomes of idiopathic VT
were excluded. Baseline characteristics and outcomes of recurrence of
VT and mortality were extracted from the included studies. Risk ratio
(RR) was calculated for the outcomes of recurrence of VT and mor-
tality using random effects model with 95% conﬁdence intervals (CI).
RESULTS A total of 8 studies (5 randomized studies) met our inclusion
criteria and included 1256 patients, 379 in the CA group and 877 in the
DT group. Follow up times varied from 6 months to 5 years. Heteroge-
neity was assessed by Cochcrane q statistic, which suggested low de-
gree of heterogeneity (I2¼25%). VT recurred in 36% and 54% of the CA
and DT groups, respectively. The overall RR of recurrence of VT was
0.67 (95% CI 0.51 – 0.89) in favor of the CA group and exclusion sensi-
tivity of the individual studies did not alter the above results. Subgroup
analysis including only randomized studies also showed a decreased
recurrence of VT after catheter ablation (RR 0.72, 95% CI 0.52 – 0.99).
Mortality was reported in 6 studies and mortality was signiﬁcantly
lower in the CA group compared to DT group (17% vs 42%). The overall
risk ofmortalitywas signiﬁcantly lower in theCA group (RR0.63, 95%CI
0.47 – 0.85). The decrease in mortality was driven by a single study
(Bunch et al.) Publication biaswas assessed bymeans of trim andﬁll plot
and was deemed to be minimal and moderate for the outcomes of VT
recurrence and mortality, respectively.
CONCLUSIONS The results of this meta-analysis suggest that the risk
of VT recurrence and mortality are decreased by 33% and 37%
respectively with CA of VT compared to DT.
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BACKGROUND Transcatheter closure of ostium secundum atrial septal
defect (ASD) by atrial septal occluder (ASO) device is aminimally invasive
and effective alternative to surgical repair of ostium secundum atrial
septal defect. This procedure is routinely been practiced with balloon
sizing and invasive echocardiographic assessment. The sizing balloon
usually costs around USD 600, which is not affordable for most of the
patients in our setting. Amethod of device closurewithout balloon sizing
had been described in recent past. We derived a sizing formula using our
initial results and oversized the device ranging from 4 to 6mm to
maximum ASD diameter measured by transthoracic echocardiogram.
This study was designed to evaluate the safety and effectiveness of
transcatheter closure of ostium secundum atrial septal defect without
balloon sizing or invasive echocardiographic assessment.
METHODS Medical records and followed up data of 128 patients who
underwent transcatheter closure of ostium secundum atrial septal defect
by atrial septal occluder device, from March 2009 to May 2014 were
analyzed. The abovementioned sizing formulawas used for device sizing
whereas ﬂuoroscopy and transthoracic echocardiogram were used for
device positioning and assessing the stability. This procedure was done
under local anesthesia. The patients were followed up with a periodic
clinical and echocardiographic evaluation and procedural out comes and
subsequent complications were retrospectively analyzed.
RESULTS Among 128 patients 68.8% (n¼88) were females and 31.2%
(n¼40) were males. Mean age was 34.713.9 with a range from 13 to 63
years. The mean ASD diameter according to the transthoracic echo-
cardiographic measurement was 17.85.1 mm ranging from 8mm to
30mm. Mean size of ASO device diameter was 22.65.5 mm ranging
from 12mm to 34mm. The ﬁnal success rate of the procedure was 91.4%
(n¼117) and failure rate was 8.6% (n¼11). No major complications such
as thromboembolic events, obstruction of intracardiac structures, car-
diac perforation, device embolization, device erosion and residual
shunting or deaths were reported during the procedure or within one
year follow up period.Minor complicationswere reported in 3.9% (n¼5)
of patients. With the use of above mentioned method, average cost per
patient excluding the device cost was USD 325.
CONCLUSIONS Transcatheter closure of ostium secundum ASD with
ASO device using device sizing formula and non-invasive trans-
thoracic echocardiographic assessment is a feasible, safe and cost
effective method which would be more appropriate for countries with
minimum resources for health care.
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BACKGROUND Surgical myectomy (SM) and alcohol septal ablation
(ASA) are the 2 invasive strategies used to relieve left ventricular
outﬂow tract obstruction (LVOTO) in patients with drug refractory
symptomatic hypertrophic cardiomyopathy (HCM). No randomized
